Protein engineering for improved pharmacologic characteristics of established monoclonal antibody-based therapeutics
Clin Pharmacokinet
.
2014 Oct;53(10):863-4.
doi: 10.1007/s40262-014-0186-6.
Author
Bernd Meibohm
1
Affiliation
1
College of Pharmacy, University of Tennessee Health Science Center, 881 Madison Avenue, Rm. 444, Memphis, TN, 38163, USA, bmeibohm@uthsc.edu.
PMID:
25212704
DOI:
10.1007/s40262-014-0186-6
No abstract available
MeSH terms
Antibodies, Monoclonal / genetics*
Antibodies, Monoclonal / pharmacokinetics
Antibodies, Monoclonal / pharmacology*
Humans
Protein Engineering*
Substances
Antibodies, Monoclonal